Approved use in Japan
In Japan, Mounjaro (tirzepatide) is approved for the treatment of type 2 diabetes. It is not approved for weight loss in Japan. Approval of a different tirzepatide product does not apply to Mounjaro. The doctor decides whether this medicine is right for you.
Who can and can't use it
Do not use it if any of these apply
- You have had an allergic reaction to any of its ingredients.
- Type 1 diabetes, diabetic ketoacidosis, or diabetic coma or pre-coma.
- You have a severe infection or need emergency care such as urgent surgery.
- You are pregnant or might be pregnant (do not use it; talk to your doctor).
Tell your doctor before treatment
- Severe digestive symptoms, a history of pancreatitis, bowel obstruction, or abdominal surgery, or eye disease caused by diabetes.
- Breastfeeding, plans to become pregnant, or a planned procedure with anesthesia or deep sedation.
- All medicines you use, including insulin, other diabetes medicines, birth control pills, and warfarin.
Do not use Mounjaro together with other tirzepatide products. Talk to your doctor before changing medicines.
Common symptoms
Nausea, vomiting, diarrhea: These can happen, especially when you start treatment or increase the dose. Constipation, stomach pain, indigestion, and decreased appetite are also listed as side effects.
If symptoms are hard to bear: Contact the prescribing doctor, and do not change your treatment on your own.
